COMP <GO>
HIMS vs UNH // FREE CASH FLOW YIELD
Hims & Hers Health Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HIMS 5
— UNH 10
▲ FREE CASH FLOW YIELD LEADER: UNH
LAST: $27.68 (-6.71%) • MKT CAP: $6.92B
fcf-yield
2.81%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
fcf-yield
6.48%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HIMS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HIMS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.80% | 88.57% | -14.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.40% | 11.47% | -3.07 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.7x | 16.4x | +21.25 | UNH | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 2.81% | 6.48% | -3.67 | UNH | /fcf-yield <GO> |
| Operating Margin | 4.50% | 4.82% | -0.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | 5.50% | 3.14% | +2.36 | HIMS | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | 6.46% | +52.54 | HIMS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.95 | 3.12 | +0.83 | HIMS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | HIMS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.74% | +0.36 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 56.0 | -11.14 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.33 | +0.72 | HIMS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.3x | 17.1x | +28.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.92B | $364.66B | -$357.74B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HIMS REV | UNH REV | HIMS GROSS % | UNH GROSS % | HIMS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.35B | $447.57B | 73.8% | 88.7% | $194.4M | $16.07B |
| FY 2024 | $1.48B | $400.28B | 79.5% | 88.3% | $184.6M | $20.70B |
| FY 2023 | $872.0M | $371.62B | 44.0% | 89.6% | $34.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HIMS // BETA 1.05
UNH // BETA 0.33